Hennessy Advisors Inc Merck & Co., Inc. Transaction History

Hennessy Advisors Inc

  • $3.26 Billion
  • Q4 2024

A detailed history of Hennessy Advisors Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hennessy Advisors Inc holds 64,950 shares of MRK stock, worth $6.21 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
64,950
Previous 46,950 38.34%
Holding current value
$6.21 Million
Previous $5.33 Million 21.2%
% of portfolio
0.2%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025
BUY
$96.31 - $114.76 $1.73 Million - $2.07 Million
18,000 Added 38.34%
64,950 $6.46 Million
Q3 2024

Oct 15, 2024
BUY
$111.15 - $128.97 $416,812 - $483,637
3,750 Added 8.68%
46,950 $5.33 Million
Q2 2024

Jul 23, 2024
SELL
$123.8 - $132.96 $111,420 - $119,664
-900 Reduced 2.04%
43,200 $5.35 Million
Q1 2024

Apr 15, 2024
BUY
$113.24 - $131.95 $4.99 Million - $5.82 Million
44,100 New
44,100 $5.82 Million
Q4 2023

Jan 18, 2024
SELL
$100.18 - $109.02 $260,468 - $283,452
-2,600 Reduced 5.36%
45,900 $5 Million
Q3 2023

Oct 18, 2023
SELL
$102.95 - $114.33 $102,950 - $114,330
-1,000 Reduced 2.02%
48,500 $4.99 Million
Q2 2023

Jul 17, 2023
SELL
$108.61 - $118.38 $304,108 - $331,464
-2,800 Reduced 5.35%
49,500 $5.71 Million
Q1 2023

Apr 14, 2023
SELL
$102.94 - $114.86 $4.37 Million - $4.88 Million
-42,500 Reduced 44.83%
52,300 $5.56 Million
Q4 2022

Jan 20, 2023
SELL
$87.44 - $112.11 $2.47 Million - $3.17 Million
-28,300 Reduced 22.99%
94,800 $10.5 Million
Q3 2022

Nov 08, 2022
SELL
$84.53 - $94.96 $355,026 - $398,832
-4,200 Reduced 3.3%
123,100 $10.6 Million
Q2 2022

Aug 12, 2022
SELL
$83.49 - $94.64 $254,644 - $288,652
-3,050 Reduced 2.34%
127,300 $11.6 Million
Q1 2022

May 12, 2022
SELL
$73.51 - $82.4 $1.63 Million - $1.83 Million
-22,200 Reduced 14.55%
130,350 $10.7 Million
Q4 2021

Jan 25, 2022
BUY
$72.28 - $90.54 $86,736 - $108,648
1,200 Added 0.79%
152,550 $11.7 Million
Q3 2021

Oct 12, 2021
BUY
$71.68 - $78.83 $351,232 - $386,267
4,900 Added 3.35%
151,350 $11.4 Million
Q2 2021

Jul 28, 2021
BUY
$70.31 - $77.77 $256,631 - $283,860
3,650 Added 2.56%
146,450 $11.4 Million
Q1 2021

Apr 19, 2021
BUY
$68.86 - $81.11 $2.64 Million - $3.11 Million
38,300 Added 36.65%
142,800 $11 Million
Q4 2020

Jan 25, 2021
BUY
$71.77 - $79.65 $1.18 Million - $1.31 Million
16,500 Added 18.75%
104,500 $8.55 Million
Q3 2020

Oct 16, 2020
SELL
$73.18 - $82.95 $131,724 - $149,310
-1,800 Reduced 2.0%
88,000 $7.3 Million
Q2 2020

Jul 20, 2020
SELL
$70.42 - $80.13 $232,386 - $264,429
-3,300 Reduced 3.54%
89,800 $6.94 Million
Q1 2020

Apr 14, 2020
BUY
$63.36 - $87.82 $4.13 Million - $5.72 Million
65,150 Added 233.09%
93,100 $7.16 Million
Q4 2019

Jan 14, 2020
SELL
$77.58 - $87.54 $2.66 Million - $3 Million
-34,300 Reduced 55.1%
27,950 $2.54 Million
Q3 2019

Oct 07, 2019
SELL
$76.08 - $82.93 $1.07 Million - $1.16 Million
-14,000 Reduced 18.36%
62,250 $5.24 Million
Q2 2019

Jul 11, 2019
BUY
$69.84 - $81.59 $237,456 - $277,406
3,400 Added 4.67%
76,250 $6.39 Million
Q1 2019

Apr 08, 2019
SELL
$69.58 - $79.36 $6.68 Million - $7.62 Million
-96,050 Reduced 56.87%
72,850 $6.06 Million
Q4 2018

Jan 14, 2019
SELL
$65.24 - $75.71 $489,299 - $567,825
-7,500 Reduced 4.25%
168,900 $12.9 Million
Q3 2018

Oct 10, 2018
BUY
$57.69 - $67.84 $1.03 Million - $1.21 Million
17,900 Added 11.29%
176,400 $12.5 Million
Q2 2018

Jul 20, 2018
BUY
$50.83 - $59.72 $190,612 - $223,950
3,750 Added 2.42%
158,500 $9.62 Million
Q1 2018

May 02, 2018
BUY
$50.96 - $59.23 $5.9 Million - $6.86 Million
115,800 Added 297.3%
154,750 $8.43 Million
Q4 2017

Jan 23, 2018
BUY
$51.62 - $61.64 $2.01 Million - $2.4 Million
38,950
38,950 $2.19 Million

Others Institutions Holding MRK

# of Institutions
3,813
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $242B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hennessy Advisors Inc Portfolio

Follow Hennessy Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hennessy Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email